Generalized Efficacy of t-PA for Acute Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2119-21251997., , 1997
A Practical Approach to the Treatment of Vasospasm
AJNR 18:1653-1660, Eskridge,J.M.,et al, 1997
Assessment of Digital EEG, Quantitative EEG, and EEG Brain Mapping
Neurol 49:277-292, Nuwer,M., 1997
Intravenous Thrombolysis for Acute Stroke
Neurol 49:14-29, Lyden,P.D.,et al, 1997
Systematic Review of Evidence on Thrombolytic Therapy for Acute Ischaemic Stroke
Lancet 350:607-614, Wardlaw,J.M.,et al, 1997
ALS Standard of Care Consensus
Neurol 48 (Suppl 4) :S33-S37997., Miller,R.G.,et al, 1997
Practice Advisory on the Trtm of ALS with Riluzole
Quality Standards Subcommittee of the AAN, Neurol 49:657-6591997., , 1997
The Diagnostic Evaluation & Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2
JAMA 278:51-57, Gutmann,D.H.,et al, 1997
Complication Rates for Carotid Endarterectomy
Stroke 28:889-890, Goldstein,L.B.,et al, 1997
Stroke Patients'Knowledge of Stroke
Stroke 28:912-915, Williams,L.S.,et al, 1997
Outcomes of Stroke Patients in Medicare Fee for Service and Managed Care
JAMA 278:119-124, 1611997., Retchin,S.M.,et al, 1997
Knowledge of Risk Among Patients at Increased Risk for Stroke
Stroke 28:916-921, Samsa,G.P.,et al, 1997
Practice Guidelines for the Use of Imaging in Transient Ischemic Attacks and Acute Stroke
Stroke 28:1480-1497, Culebras,A.,et al, 1997
Attitudes of US Neurologists Concerning the Ethical Dimensions of Managed Care
Neurol 49:4-13, Bernat,J.L.,et al, 1997
Managed Care and Neurologists:Ethical Considerations
Ethics & Humanities Subcomm of Practice Comm of AAN, Neurol 49:321-32297., , 1997
Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997
Silicone Breast Implants and Neurologic Disorders
Neurol 48:1504-1507, Ferguson,J.H., 1997
Optic Pathway Gliomas in Children with Neurofibromatosis 1:Consensus Stmt NF1 Optic Pathway Glioma Task Force
Ann Neurol 41:143-149, Listernick,R.,et al, 1997
Consensus Against Both Endarterectomy and Routine Screening for Asymptomatic Carotid Artery Stenosis
Arch Neurol 54:25-28, 231997., Perry,J.R.,et al, 1997
Thromboembolism Prophylaxis in Chronic Atrial Fibrillation:Practice Patterns in Community & Tertiary-Care Hosp
Stroke 28:72-76, Munschauer,F.E.,et al, 1997
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Withdrawing Intensive Life-Sustaining Treatment-Recommendations for Compassionate Clin Mgmt
NEJM 336:652-657, Brody,H.,et al, 1997
Feasibility and Effects of Nurse Run Clinics for Pts with Epilepsy in General Practice:Randomised Controlled Trial
BMJ 314:120-122, Ridsdale,L.,et al, 1997
Diagnosis and Management of Concussion in Sports
Neurol 48:575-580, 5811997., Kelly,J.P.&Rosenberg,J.H., 1997
On Guidelines for the Management of the Severe Head Injury
JNNP 62:109-111, Kirkpatrick,P.J., 1997
Pharmacological Management of Alcohol Withdrawal
JAMA 278:144-151, Mayo-Smith,M.F., 1997
A Controlled Trial of an Educational Program to Prevent Low Back Injuries
NEJM 337:322-328, Daltrov,L.H.,et al, 1997
Dermatomal Somatosensory Evoked Potentials
AAN Therapeutics & Technology Assessments Subcommittee, Neurol 49:1127-113097., , 1997
Laboratory Evaluation in the Diagnosis of Lyme Disease
Ann Int Med 127:1109-1123, 1106-11081997., Tugwell,P.,et al, 1997
Diagnosing Syncope, Part 2:Unexplained Syncope
Ann Int Med 127:76-86, Linzer,M.,et al, 1997
Evaluation of Dementia:A Systematic Study of the Usefulness of the AAN Practice parameters
Neurol 49:925-935, Chui,H.&Zhang,Q., 1997
The Delay in Reporting Symptoms of Carotid Artery Stenosis in an At-Risk Population
Arch Neurol 54:1267-1271, Castaldo,J.E.,et al, 1997
Patients'Awareness of Stroke Signs, Symptoms & Risk Factors
Stroke 28:1871-1875, Kothari,R.,et al, 1997
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Practice Parameter:Genetic Testing Alert
Pract Comm Genet Testing Task Force AAN, Neurol 47:1343-13441996., , 1996
Evaluation of Dementia
NEJM 335:330-336, 19961996., Geldmacher,D.S.&Whitehouse,P.J., 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Practice Parameters for the Diagnosis of Patients with Nervous System Lyme Borreliosis (Lyme Disease)
Neurol 46:619-627, 8811996., Halperin,J.J.,et al, 1996
Neuroimaging in the Emergency Patient Presenting with Seizure
Neurol 47:26-32, 2881996., Greenberg,M.K.,et al, 1996
Assessment:Electronystagmography, Report of the Therapeutics and Technology Assessment Subcommittee
Neurol 46:1763-1766, Ferguson,J.H.,et al, 1996
Practice Parameter:A Guideline for Discontinuing Antiepileptic Drugs in Seizure-Free Patients-Summary Statement
Neurol 47:600-602, Rosenberg,J.H., 1996
Practice Parameter:The Neurodiagnostic Evaluation of the Child with First Simple Febrile Seizure
Pediatrics 97:769-772, Bergman,D.A.,et al, 1996
Living with Parkinson's Disease
NEJM 334:114-116, Salzman,E.W., 1996
Results of a Computerized Screening of Stroke Patients for Unjustified Hospital Stay
Stroke 27:639-644, Goldman,R.S.,et al, 1996
US NEurologists:Attitudes on the US Health Care System
Neurol 47:279-287, Ringel,S.P.,et al, 1996
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
Assessment of Plasmapheresis
Report of the Therapeutics and Technology Assessment Subcommittee of the AAN, Neurol 47:840-8431996., , 1996
Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996